Fig. 2From: Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in SpainPharmacological treatment distribution in each line of treatment after metastatic relapse. 1L: first-line; 2L: second-line; 3L: third-line; 4L; forth-lineBack to article page